Daniel P. O'Day
Overview
Daniel P. O'Day received an average of $22M in total compensation, including $2M in salary, at Gilead Sciences from 2019 to 2021.
Source: SEC filings on March 24, 2022, March 30, 2021, and March 24, 2020.
Related executives
We found 14 more executives who work or worked at Gilead Sciences.
Johanna Mercier
Gilead Sciences
Chief Commercial Officer
Merdad Parsey
Gilead Sciences
Chief Medical Officer
Andrew Dickinson
Gilead Sciences
Chief Financial Officer
Brett Pletcher
Gilead Sciences
General Counsel
Gregg Alton
Gilead Sciences
Chief Executive Officer
Laura Hamill
Gilead Sciences
Former Executive Vice President Worldwide Commercial Operations
Robin Washington
Gilead Sciences
Chief Financial Officer
John McHutchison
Gilead Sciences